8-KThe WireRoutine
Bylaw Amendment
Filed Jul 7, 2021 · 5y ago · Accession 0001193125-21-209937
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acumen Pharmaceuticals, Inc.
- Ticker
- ABOS
- CIK
- 1576885
- Form type
- 8-K
- Filing date
- Jul 7, 2021
- Report date
- Jul 6, 2021
- Document
- d147948d8k.htm
- Size
- 155 KB